Teachers Retirement System of The State of Kentucky Buys 47,620 Shares of Alignment Healthcare, Inc. $ALHC

Key Points

• Teachers Retirement System of the State of Kentucky increased its stake in Alignment Healthcare by 103.4%, buying an additional 47,620 shares to hold 93,685 shares valued at about $1.85 million at quarter-end.
• Significant insider selling occurred recently: CEO John Kao sold 250,000 shares and insiders sold 1,474,097 shares worth $28.68 million in the last quarter, leaving insiders with 6.60% ownership.
• Analysts are mostly positive—Alignment Healthcare has a consensus "Moderate Buy" rating with an average price target of $24.67 after several target increases—and the company recently beat EPS estimates while reporting revenue up 44.4% year-over-year.

Teachers Retirement System of The State of Kentucky lifted its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 103.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 93,685 shares of the company's stock after acquiring an additional 47,620 shares during the period. Teachers Retirement System of The State of Kentucky's holdings in Alignment Healthcare were worth $1,850,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Larson Financial Group LLC bought a new position in shares of Alignment Healthcare in the third quarter worth $33,000. First Horizon Corp bought a new position in shares of Alignment Healthcare in the fourth quarter worth $39,000. GAMMA Investing LLC boosted its holdings in shares of Alignment Healthcare by 83.8% in the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company's stock worth $43,000 after acquiring an additional 987 shares during the period. Wilmington Savings Fund Society FSB purchased a new stake in shares of Alignment Healthcare in the third quarter worth $53,000. Finally, PNC Financial Services Group Inc. raised its position in shares of Alignment Healthcare by 205.6% in the third quarter. PNC Financial Services Group Inc. now owns 3,459 shares of the company's stock worth $60,000 after buying an additional 2,327 shares in the last quarter. 86.19% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Alignment Healthcare news, CEO John E. Kao sold 250,000 shares of the company's stock in a transaction that occurred on Tuesday, April 7th. The stock was sold at an average price of $21.01, for a total transaction of $5,252,500.00. Following the transaction, the chief executive officer owned 2,104,641 shares in the company, valued at approximately $44,218,507.41. This represents a 10.62% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Dawn Christine Maroney sold 36,749 shares of the business's stock in a transaction that occurred on Wednesday, March 18th. The stock was sold at an average price of $17.84, for a total value of $655,602.16. Following the completion of the sale, the president directly owned 1,058,813 shares in the company, valued at approximately $18,889,223.92. This represents a 3.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 1,474,097 shares of company stock worth $28,679,550 in the last quarter. Company insiders own 6.60% of the company's stock.

Analyst Ratings Changes

ALHC has been the topic of a number of recent analyst reports. UBS Group increased their price objective on Alignment Healthcare from $18.00 to $21.00 and gave the stock a "neutral" rating in a research report on Wednesday, January 14th. Wolfe Research initiated coverage on Alignment Healthcare in a research report on Friday, April 17th. They issued an "outperform" rating and a $24.00 price objective on the stock. JPMorgan Chase & Co. increased their price objective on Alignment Healthcare from $23.00 to $26.00 and gave the stock an "overweight" rating in a research report on Thursday, February 5th. KeyCorp reiterated an "overweight" rating and issued a $28.00 price objective on shares of Alignment Healthcare in a research report on Thursday, January 22nd. Finally, Robert W. Baird set a $28.00 price objective on Alignment Healthcare in a research report on Friday, January 30th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Alignment Healthcare currently has an average rating of "Moderate Buy" and an average price target of $24.67.

Alignment Healthcare Trading Up 4.5%

NASDAQ ALHC opened at $21.90 on Wednesday. The stock's 50-day simple moving average is $19.33 and its two-hundred day simple moving average is $19.38. Alignment Healthcare, Inc. has a twelve month low of $11.63 and a twelve month high of $23.87. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.80. The company has a market capitalization of $4.53 billion, a price-to-earnings ratio of -2,187.81, a PEG ratio of 4.30 and a beta of 1.20.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, beating analysts' consensus estimates of ($0.15) by $0.10. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The business had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1 billion. During the same quarter last year, the business posted ($0.16) earnings per share. The company's revenue for the quarter was up 44.4% on a year-over-year basis. Research analysts forecast that Alignment Healthcare, Inc. will post 0.13 EPS for the current fiscal year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc NASDAQ: ALHC is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.